Cash, Cash Equivalents, and Marketable Securities - Summary of Cash, Cash Equivalents, and Marketable Securities (Details) - USD ($)
|
Dec. 31, 2021 |
Dec. 31, 2020 |
| Schedule Of Available For Sale Securities [Line Items] |
|
|
| Cash and cash equivalents, Amortized Cost |
$ 34,688,880
|
$ 4,241,937
|
| Cash and cash equivalents, Unrealized Gain |
|
|
| Cash and cash equivalents, Unrealized (Loss) |
|
|
| Cash and cash equivalents |
34,688,880
|
4,241,937
|
| Marketable securities, Amortized Cost |
421
|
18,388,970
|
| Marketable securities, Unrealized Gain |
|
|
| Marketable securities, Unrealized (Loss) |
(421)
|
(2,810)
|
| Marketable securities, Fair Value |
|
18,386,160
|
| Cash, cash equivalents and marketable securities, Amortized Cost |
34,689,301
|
22,630,907
|
| Cash, cash equivalents and marketable securities, Unrealized Gain |
|
|
| Cash, cash equivalents and marketable securities, Unrealized (Loss) |
(421)
|
(2,810)
|
| Cash, cash equivalents and marketable securities, Fair Value |
34,688,880
|
22,628,097
|
| U.S. Treasury Bonds |
|
|
| Schedule Of Available For Sale Securities [Line Items] |
|
|
| Marketable securities, Amortized Cost |
421
|
18,388,970
|
| Marketable securities, Unrealized Gain |
|
|
| Marketable securities, Unrealized (Loss) |
(421)
|
(2,810)
|
| Marketable securities, Fair Value |
|
$ 18,386,160
|